Literature DB >> 16491648

Appetite regulatory peptides in Indian Antarctic expeditioners.

Praveen Vats1, Som Nath Singh, Vijay Kumar Singh, Radhey Shyam, T N Upadhyay, S B Singh, P K Banerjee.   

Abstract

Antarctica presents an inhospitable environment due to extreme low temperature, high wind velocity, low humidity, snowstorms, long polar days and nights, high level of UV radiations, magnetic storms and increased ionisation along with social isolation and sexual deprivation. Acclimatisation to any new condition is associated with certain metabolic changes along with alteration in nutritional requirements. There are reports of increased food intake and gain in body weight during past Indian Antarctic expeditions. Therefore, the present study was undertaken with the aim to assess the changes in appetite regulatory peptides i.e. leptin and neuropeptide Y in relation to energy intake and expenditure of the Antarctic expeditioners. The study was conducted in three phases viz. Phase I at Goa (basal), Phase II 48 h after reaching Antarctica and Phase III after one month of stay at Antarctica. Energy and nutrient intake were analysed from the duplicate plate samples of the expeditioners. Energy expenditure was computed using 24 h activity records for 7 days. Blood samples were collected in each phase for biochemical estimations. After reaching Antarctica, the expeditioners were active and the total energy expenditure (mean +/- SEM, n = 10) was found to be 3120 +/- 474 kcal/day. The actual energy intake was found to be 3911 +/- 310 kcal/day. This indicates that the Antarctic expeditioners had very active life and weight gain during expedition could be due to positive energy balance. After 48 h of stay at Antarctica plasma leptin levels (mean +/- SEM, n = 22) decreased from normal basal values 5.66 (+/- 0.59) ng/ml (Phase I) to 4.40 (+/- 0.37) ng/ml (Phase II), even though there was an increase in body fat. Increased level of plasma leptin was observed in Phase III as compared to phase I and II. Concomitantly there was increase in plasma neuropeptide Y levels from 0.303 (+/- 0.004) ng/ml to 1.211 (+/- 0. 27) ng/ml (p < 0.001) in Phase II and decrease in Phase III. The decrease in plasma leptin levels and increase in neuropeptide Y levels in Phase II may be responsible for increase in appetite and gain in body weight at Antarctica.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16491648     DOI: 10.1080/10284150500193726

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  5 in total

1.  Circulating brain-derived neurotrophic factor, leptin, neuropeptide Y, and their clinical correlates in cystic fibrosis: a cross-sectional study.

Authors:  Jan K Nowak; Mariusz Szczepanik; Magdalena Trypuć; Andrzej Pogorzelski; Waldemar Bobkowski; Marcin Grytczuk; Alina Minarowska; Rafał Wójciak; Jaroslaw Walkowiak
Journal:  Arch Med Sci       Date:  2018-04-23       Impact factor: 3.318

2.  A longitudinal study of the effect of Antarctic residence on energy dynamics and aerobic fitness.

Authors:  Alistair Simpson; Veronica Maynard
Journal:  Int J Circumpolar Health       Date:  2012-03-19       Impact factor: 1.228

3.  Seasonal variation in the voluntary food intake of domesticated cats (Felis catus).

Authors:  Samuel Serisier; Alexandre Feugier; Sébastien Delmotte; Vincent Biourge; Alexander James German
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

4.  Changes of 25-OH-Vitamin D during Overwintering at the German Antarctic Stations Neumayer II and III.

Authors:  Mathias Steinach; Eberhard Kohlberg; Martina Anna Maggioni; Stefan Mendt; Oliver Opatz; Alexander Stahn; Josefine Tiedemann; Hanns-Christian Gunga
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

5.  Effect of yoga or physical exercise on physical, cognitive and emotional measures in children: a randomized controlled trial.

Authors:  Shirley Telles; Nilkamal Singh; Abhishek Kumar Bhardwaj; Ankur Kumar; Acharya Balkrishna
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2013-11-07       Impact factor: 3.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.